Blog - Page 4869 of 5778

MondayApr 07, 2008 7:39 am

StockGuru Blog: NextGen Bioscience (NXGB) – Business Model to Acquire Promising New Patented Technologies in Fields of Cancer and Infectious Disease

NextGen Bioscience, Inc., a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers. The Company is focused on the discovery, development and commercialization of novel therapeutics to fight prostate and breast cancer. All of NextGen’s product candidates target disease indications which represent a significant unmet need, as well as having substantial potential market values. NextGen’s business model is to acquire promising new patented technologies in the fields of cancer and infectious disease, to add significant value to these by advancing them through toxicological assessment or Phase I clinical trials and then outlicensing the technology to…

MondayApr 07, 2008 6:10 am

eDOORWAYS Corp. (EDWY.PK) Retains speakTECH to Build Technology Platform

eDOORWAYS Corporation announced that it has hired speakTECH, a national software consulting firm, to build its service platform. speakTECH focuses on delivering solutions for business of different sizes that are in demanding enterprise environments. The company has expertise in consulting, designing, and developing services, as well as identifying and improving operational flow while building its customized client solutions. Based in Costa Mesa, CA, speakTECH has provided services to a number of internet service provider companies and maintains clients in the following industries: Financial Services, Manufacturing, Health Care, Media and Entertainment, and the Public sector. Gary Kimmons, CEO of eDOORWAYS, said,…

MondayApr 07, 2008 4:32 am

Biopure Corp. (BPUR) Receives Comment Letter From the U.K.

This morning, Biopure Corporation (Nasdaq: BPUR) announced that it has received a comment letter from the United Kingdom's Commission on Human Medicines addressing the company's application for marketing authorization for Hemopure [(R) hemoglobin glutamer - 250 (bovine)] pending with the Medicines and Healthcare products Regulatory Agency (MHRA). The commission was reassured on a number of questions raised in the initial comment letter. The comment letter invites Biopure to discuss the issues with the MHRA team. Biopure has not been advised to withdraw its application. "We intend to proceed by meeting and consulting with the UK regulatory review team, as suggested,…

MondayApr 07, 2008 4:26 am

Why Kensey Nash Corporation (KNSY) Has Excellent Business Prospects

Institutions own virtually all the stock, but retail investors should not feel left out as there are nearly 12 million stocks available for trade. The stock price is very close to the 52-week high at the end of the first week of April 2008, and some say the stock appears on course to gain new price heights on NASDAQ. The company is in the dynamic Medical Equipment & Supplies Industry. This is an optimal part of the Healthcare Sector. The core technology of this company is making devices and surgical aids from materials that can be used inside the human…

MondayApr 07, 2008 4:17 am

Teton Energy Corp. (TEC) Has Extraordinary Business Strength

Every investor dreams of discovering top small capital stock picks. Here is a possible candidate. The market capitalization is less than $90 million at the end of the first week of April 2008, and shares are available for less than $5. What does Teton have that is so exciting in business terms? The company is truly independent in every sense of the term. Institutions own less than 40% of the stock. All its natural energy assets are in the North American continent; no Chavez can take away its assets on a whim. Natural gas makes up the vast majority of…

MondayApr 07, 2008 4:05 am

Global Roaming Distribution, Inc. (GRDB.OB) Announces Promotion through QualityStocks.net

Global Roaming Distribution will be featured in upcoming Daily Newsletters, Daily Blogs, Message Boards, and the Small Cap Daily Internet broadcasts put out by QualityStocks. QualityStocks has over 600,000 subscribers to The Daily Stock Newsletter, which is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters and puts it all into one Free Daily Newsletter Report. Yakov Sarousi, CEO and President of Global Roaming Distribution, has the company focused on offering extremely low-cost roaming solutions for corporations and leisure travelers around the globe. According to Mr. Sarousi, “Global Roaming Distribution has a unique and…

MondayApr 07, 2008 3:47 am

Tecton Corp. (TTNC.OB) – Working for the Ethical Use of Nuclear Power

When the average person thinks about nuclear power, those thoughts are often bathed in an extraordinarily negative light. While uranium, the most common source from which nuclear energy is derived, does have some truly sinister applications, it can also be used for good. Uranium powers many of the ships and submarines used for the protection of our borders, as well as safeguarding our interests overseas. In addition, nuclear power plants currently generate 16% of the world's electricity, without the harmful emissions caused by their coal-powered counterparts. Tecton Corporation has committed itself to never providing uranium under any circumstance in which…

SundayApr 06, 2008 7:49 am

StockGuru Announces Coverage of: NextGen Bioscience (NXGB)

NextGen Bioscience, Inc. (OTC: NXGB) is a drug development biotechnology company focused on the identification, evaluation and acquisition of drug candidates for treatment and prevention of oncological and infectious diseases in human beings. All product candidates target indications with significant unmet need and substantial market potential. Subsequent value-addition at low cost brings benefits to both patients and stakeholders. These programs will then be transferred to larger organizations, either other biotech companies and/or Big Pharma, who have the infrastructure to bring the products to market. All acquisition candidates are underpinned by patent applications or granted patents which confer protection in the…

SundayApr 06, 2008 7:48 am

StockGuru Blog: More from New Profile NextGen Bioscience (NXGB)

NextGen Bioscience, Inc. is a drug development biotechnology company focused on the identification, evaluation and acquisition of drug candidates for treatment and prevention of oncological and infectious diseases in human beings. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical companies. NextGen’s business model is to acquire promising new patented technologies in the fields of cancer and infectious disease, to add significant value to these by advancing them through toxicological assessment or Phase I clinical trials and then outlicensing the technology to a larger partner who…

SundayApr 06, 2008 7:47 am

StockGuru Blog: NextGen Bioscience (NXGB) – Biotechnology Company with World Class Management

NextGen Bioscience, Inc. is a drug target acquisition and development company focused on identifying, evaluating and acquiring pioneering innovative cancer research patents, and adding substantial value to those products to demonstrate ‘proof of principle’. The Company is focused on the discovery, development and commercialization of novel therapeutics to fight cancer, in prostate and breast cancer. “NextGen” leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical companies. All acquisition candidates are underpinned by patent applications or granted patents which confer protection in the major jurisdictions worldwide. NextGen’s business model…

Site Search

Company Search